Поиск

Автор

Ключевое слово

Коллекция

Дополнительно:

Период публикации

Научный руководитель

Оппонент

По вашему запросу найдено документов: 1358

Страница 1 из 136

Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients

Khamidullina, Zemfira, Avzaletdinova, Diana, Gareeva, Diana, Morugova, Tatyana, Lakman, Irina, Kopp, Kristen, Fiedler, Lukas, Motloch, Lukas J., Zagidullin, Naufal (2024)

of hospitalized patients with COVID-19 with or without T2D in the hospital and at 10-month follow-up (FU). Methods

Смертность при разных штаммах COVID-19 в отдаленном периоде: 18-месячное наблюдение

Long-term mortality in different COVID-19 variants: 18-month follow-up

Lakman, I.A., Gareeva, D.F., Sadikova, L.F., Agapitov, A.A., Davtyan, P.A., Kayumova, V.L., Timiryanova, V.M., Zagidullin, N.Sh., Лакман, И. А., Гареева, Д. Ф., Садикова, Л. Ф., Агапитов, А. А., Давтян, П. А., Каюмова, В. Л., Тимирьянова, В. М., Загидуллин, Н.Ш. (2023)

Long-term mortality in different COVID-19 variants: 18-month follow-up

Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation

Onorato, EM, Alamanni, F, Muratori, M, Smolka, G, Wojakowski, W, Pysz, P, Zorinas, A, Zakarkaite, D, Eltchaninoff, H, Litzer, PY, Godart, F, Calvert, P, Christou, C, Mussayev, A, Missiroli, B, Buzaev, I, Curello, S, Tesorio, T, Bartorelli, AL (2022)

80% at baseline to 14.1% at 2-year follow-up (FAS). The proportion of FAS patients needing hemolysis

EFFECTIVENESS AND SAFETY OF LONG-TERM TREATMENT WITH SULFONYLUREAS IN PATIENTS WITH NEONATAL DIABETES DUE TO KCNJ11 MUTATIONS: AN INTERNATIONAL COHORT STUDY

Neonatal Diabet Int Collaborative (2018)

with excellent initial glycaemic control; however, whether this control is maintained in the long term is unclear

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia

Fiedler, L., Motloch, L.J., Jirak, P., Gumerov, R., Davtyan, P., Gareeva, D., Lakman, I., Tataurov, A., Lasinova, G., Pavlov, V., Hauptmann, L., Kopp, K., Hoppe, U.C., Lichtenauer, M., Pistulli, R., Dieplinger, A.-M., Zagidullin, N. (2022)

Introduction: COVID-19 survivors reveal an increased long-term risk for cardiovascular disease

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors

) system according to recent data, an increased CV risk has been reported also during long-term follow-up

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia

Motloch, LJ;, Jirak, P;, Gareeva, D;, Davtyan, P;, Gumerov, R;, Lakman, I;, Tataurov, A;, Zulkarneev, R;, Kabirov, I;, Cai, BZ;, Valeev, B;, Pavlov, V;, Kopp, K;, Hoppe, UC;, Lichtenauer, M;, Fiedler, L;, Pistulli, R;, Zagidullin, N (2022)

-TnI might predict post-discharge mortality in long term follow-up.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial

Onorato, Eustaquio Maria, Onorato, Eustaquio Maria, Muratori, Manuela, Smolka, Grzegorz, Wojakowski, Wojtek, Pysz, Piotr, Zorinas, Aleksejus, Zakarkaite, Diana, Eltchaninoff, Hélène, Litzer, Pierre-Yves, Godart, François, Calvert, Patrick, Christou, Christos, Mussayev, Abdurashid, Missiroli, Bindo, Buzaev, Igor, Curello, Salvatore, Tesorio, Tullio, Bartorelli, Antonio Luca (2022)

to 14.1% at 2-year follow-up (FAS). The proportion of FAS patients needing hemolysis-related blood

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

Motloch, L.J., Jirak, Peter, Mirna, Moritz, Fiedler, Lukas, Davtyan, P.A., Lakman, I.A., Gareeva, D.F., Tyurin, A.V., Gumerov, R.M., Matskeplishvili, S.T., Pavlov, V.N., Cai, Benzhi, Kopp, Kristena, Topf, Alberta, Hoppe, Uta C., Pistulli, Rudini, Zagidullin, N.S. (2022)

follow-up (393 ± 87 days) of 1,746 consecutive patients, hospitalized with and surviving COVID-19

J-ВОЛНА И КАРДИОСПЕЦИФИЧЕСКИЕ БИОМАРКЕРЫ КОРРЕЛИРУЮТ С ОТДАЛЕННЫМИ СЕРДЕЧНО-СОСУДИСТЫМИ ОСЛОЖНЕНИЯМИ У ПАЦИЕНТОВ, ГОСПИТАЛИЗИРОВАННЫХ С COVID-АССОЦИИРОВАННОЙ ПНЕВМОНИЕЙ

J-WAVES AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

Diana, Gareeva F., Irina, Lakman A, Alexander, Agapitov A., Liana, Sadikova F., Venera, Timiryanova M., Naufal, Zagidullin Sh, Гареева, Д.Ф., Лакман, И.А., Агапитов, А.А., Садикова, Л.Ф., Тимирьянова, В.М., Загидуллин, Н.Ш. (2024)

J-WAVES AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES

Страница 1 из 136